As a class, sodium–glucose transporter 2 inhibitors are ... In contrast to most non-insulin medications used in type 2 diabetes (T2D) treatment, SGLT2 inhibitors achieve glucose reduction ...

Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at ...

SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.

Systolic BP (mmHg):/DP: −2.1 to −5.1 Diastolic ... the SGLTs secondary active Na + /D-glucose co-transporters located at the brush border of tubular cells (SGLT2 and SGLT1) and the GLUTs ...

Objective Sodium–glucose cotransporter 2 (SGLT-2) inhibitors are the most recently approved antihyperglycemic medications. We sought to describe their association with euglycemic diabetic ...

SGLT-2 inhibitors, compared with DPP-4 inhibitors, were associated with a lower risk for liver cirrhosis among patients with type 2 diabetes. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors ...

The biggest advantage of the drug going off patent is that the prices will plummet. The patented medicine, sold as Jardiance, ...

Alkem Laboratories on Wednesday said it has launched a generic medication for the treatment of type-2 diabetes mellitus, ...

Share on Pinterest GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images. Researchers estimate the number of people ...

Alkem Laboratories Ltd announced the launch of generic empagliflozin and its combinations in India under the brand name “Empanorm” at prices that are approximately 80% lower than the innovator ...